[1]
A. Purnamayanti, S. Suharjono, and M. Rahmadi, “Optimization of ADMET Properties Prediction for Remdesivir, Favipiravir, and their Metabolites Elimination Profiles”, Borneo J Pharm, vol. 9, no. 1, pp. 71–76, Mar. 2026, doi: 10.33084/bjop.v9i1.8464.